N-propargyl caffeate amide

has both neuritogenic and neuroprotective activities; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Fibrosis (Cirrhosis) 01/01/2020 - "The aim of the present study was to investigate whether N-propargyl caffeate amide (PACA) could suppress myocardial fibrosis via regulating macrophage polarization. " 01/01/2020 - "N-Propargyl caffeate amide (PACA) prevents cardiac fibrosis in experimental myocardial infarction by promoting pro-resolving macrophage polarization."
2.	Myocardial Infarction 01/01/2020 - "N-Propargyl caffeate amide (PACA) prevents cardiac fibrosis in experimental myocardial infarction by promoting pro-resolving macrophage polarization."